hit and run, fill the gap today or next week, strong indicators, incoming news
PharmaCyte Biotech, Inc., a biotechnology company, focuses on developing and commercializing cellular therapies for cancer and diabetes in the United States.
PMCB displays a very clear change in direction of trend following a basing process that includes a type specimen MACD Bullish Divergence. ------------------------------------ Pharmacyte Biotech Inc (OTCMKTS:PMCB) Pharmacyte trumpets itself as a clinical stage biotechnology company that focuses on developing and commercializing cellular therapies for cancer and...
This is right time for applying "Buy low sell high" strategy on this stock and price also consolidation on strong support level. Lot of great information on this link emerging-stocks.market Very big deal to buy PMCB and I am watching this bio that has a high potential to be bought out in my opinion. Congrats to longs!